In a report released yesterday, Gianluca Mozzali from Corporate Family Office SIM maintained a Buy rating on Valtecne S.p.A., with a price target of €8.50.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Gianluca Mozzali has given his Buy rating due to a combination of factors that highlight Valtecne S.p.A.’s potential for growth despite recent challenges. The Medical Devices division, which constitutes a significant portion of the company’s revenue, has demonstrated strong organic growth of 6.9% year-over-year, outperforming the broader orthopaedics market. This growth trajectory is supported by increased volumes across all product categories, indicating a robust demand for Valtecne’s offerings.
Moreover, while the Industrial division has faced a downturn, this has been partially offset by Utilità’s strategic exposure to the Aerospace sector, which is benefiting from favorable market conditions. The company’s order backlog is near all-time highs, suggesting potential for accelerated growth in the latter half of the year. Despite a slight decline in overall sales, the underlying performance and strategic positioning in high-growth sectors justify the Buy rating, as future prospects appear promising.
VLT’s price has also changed slightly for the past six months – from EUR6.400 to EUR6.550, which is a 2.34% increase.